MLV analyst Thomas Yip came out with his views on OXiGENE Inc (NASDAQ:OXGN), after the company reported its first-quarter results and hosted a call to discuss the latest progress …
In a research report published Wednesday, MLV analyst Thomas Yip reiterated a Buy rating on OXiGENE Inc (NASDAQ:OXGN) with a $6.50 price target, after the company …
In a research report released Friday, MLV & Co. analyst Thomas Yip reiterated a Buy rating on Peregrine Pharmaceuticals (NASDAQ:PPHM) with a $3.
In a research report released Tuesday, MLV analyst Thomas Yip maintained a Buy rating on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) with a $14.
